Mechanistic insights into Metformin-induced tumor suppression: Metformin, the widely used drug in the treatment of NIDDM, inhibits replication licensing and tumorigenesis via down regulation of CDC6, 12/August/2014, 6.41 am

Mechanistic insights into Metformin-induced tumor suppression: Metformin, the widely used drug in the treatment of NIDDM, inhibits replication licensing and tumorigenesis via down regulation of CDC6, 12/August/2014, 6.41 am

Mechanistic insights into Metformin-induced tumor suppression: Metformin, the widely used drug in the treatment of NIDDM, inhibits replication licensing and tumorigenesis via down regulation of CDC6, 12/August/2014, 6.41 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan,  Mechanistic insights into Metformin-induced tumor suppression: Metformin, the widely used drug in the treatment of NIDDM, inhibits replication licensing and tumorigenesis via down regulation of CDC6, 12/August/2014,  6.41 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing